Home › Funds › Motley Fool Wealth Management, LLC › VRTX

Motley Fool Wealth Management, LLC position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Motley Fool Wealth Management, LLC reported holding 636 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$316K, representing 4.80% of its reported portfolio and ranking #10 among its reported holdings. Motley Fool Wealth Management, LLC has disclosed VRTX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)636 sh
Reported value held$316.10K
Portfolio Weight4.80%
First reportedQ1 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Motley Fool Wealth Management, LLC's VRTX position evolved

Motley Fool Wealth Management, LLC first disclosed a stake in VRTX in Q1 2024 at 42,074 shares (US$17.6M). The position peaked in Q3 2025 at 71,349 shares, worth US$27.9M. Across 10 filings, Motley Fool Wealth Management, LLC increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 636 shares valued at US$316K — a reduction of -42,200 shares quarter over quarter.. Notable position changes include a 63% increase in Q2 2025 (shares fell 12% over the following quarter), a 32% increase in Q3 2025 (shares rose 16% over the following quarter), a 99% trim in Q2 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 42.07K $17.59M New
Q2 2024 41.24K $19.44M Reduce
Q3 2024 39.49K $18.37M Reduce
Q4 2024 36.46K $14.73M Reduce
Q1 2025 33.05K $16.02M Reduce
Q2 2025 53.91K $24.00M Add
Q3 2025 71.35K $27.94M Add
Q4 2025 59.54K $26.99M Reduce
Q1 2026 42.84K $19.13M Reduce
Q2 2026 636 $316.10K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Motley Fool Wealth Management, LLC held VRTX?

Motley Fool Wealth Management, LLC has disclosed VRTX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is Motley Fool Wealth Management, LLC's current position in VRTX?

As of Q2 2026, Motley Fool Wealth Management, LLC holds 636 shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $316.10K, representing 4.80% of its reported portfolio and ranking #10.

Has Motley Fool Wealth Management, LLC been buying or selling VRTX?

In the latest 13F filing (Q2 2026), Motley Fool Wealth Management, LLC reduced its position in VRTX. The position peaked in Q3 2025 at 71.35K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.